Premedium Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 22.00 Cr
- Paid Up Capital ₹ 21.79 Cr
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.00 Cr
- Revenue Growth -23.70%
- Profit Growth 30.76%
- Ebitda 182.67%
- Net Worth -136.47%
- Total Assets -63.60%
About Premedium Pharmaceuticals
Premedium Pharmaceuticals Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 09 October 2018 (Six years and four months 22 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 22.00 Cr and a paid-up capital of Rs 21.79 Cr.
The company has closed loans amounting to ₹1.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Premedium Pharmaceuticals Private Limited India are Vivek Anand as CFO and Amit Kumar as Company Secretary. Sanjiv Kothari, Dilip Birdi, and Saras Malik serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24200DL2018PTC340319
- Company No.
340319
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2018
- Date of AGM
22 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
What products or services does Premedium Pharmaceuticals Private Limited offer?
Premedium Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Injectable Products, Anti Infective Drugs & Medicines, Anti Infective Agent, Antifungal Injection, Tablet & Syrup, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Digestive System Drugs & Medicines, Antiemetic, Sexual Wellness Products.
Who are the key members and board of directors at Premedium Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vivek Anand | CFO | 15-Sep-2022 | Current |
| Amit Kumar | Company Secretary | 20-Mar-2023 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilip Birdi  | Whole-Time Director | 30-Dec-2019 | Current |
| Sanjiv Kothari | Director | 09-Oct-2018 | Current |
| Saras Malik | Director | 14-Aug-2019 | Current |
Financial Performance of Premedium Pharmaceuticals.
Premedium Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 23.7% decrease. The company also saw a substantial improvement in profitability, with a 30.76% increase in profit. The company's net worth observed a substantial decline by a decrease of 136.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Premedium Pharmaceuticals?
In 2021, Premedium Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹0
Satisfied Charges
₹1.00 Cr
Charges Breakdown by Lending Institutions
- Others : 1.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Aug 2019 | Others | ₹1.00 Cr | Satisfied |
How Many Employees Work at Premedium Pharmaceuticals?
Premedium Pharmaceuticals has a workforce of 12 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Premedium Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Premedium Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
